Clinical Trial Update: Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating erlotinib in patients with progressive glioblastoma multiforme has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: TERMINATED